
Graphite Ventures' $120M fund, backed by Ontario and OMERS, targets the $5M-$25M funding gap; 50% US tariffs pressure Canadian startups to sell or move south.
Washington's 50 percent tariffs on Canadian goods should be met with more Canadian venture capital, not counter-tariffs, Graphite Ventures managing director Aaron Bast argues.
Bast laid out the case in an opinion piece for BetaKit. Ottawa cannot outspend Silicon Valley, he wrote. American venture firms hold the most capital. Canada's opportunity is to be the first-conviction investor in founders building durable, globally competitive businesses before the rest of the world fully understands what they are building.
The tariffs, announced last month, cover a broad list of Canadian goods, hockey sticks included. Prime Minister Mark Carney responded that Canada is ready "because we have been focusing on what we can control." What Canada controls is capital, Bast wrote.
Bast credits the federal AI strategy, the push toward Canadian-controlled investment, the economic sovereignty agenda, and the Ontario Municipal Employees Retirement System's (OMERS) commitment to add at least $10 billion in new Canadian investment over five years. Together they shifted the question from whether Canada should bet on itself to how the bet should be made, he wrote.
Canadian early-stage funding is in a sustained decline, RBCx has found. Bast puts the risk in the "valley of death," the financing gap between $5 million and $25 million. The failure that comes before the gap, at the seed stage, is just as real, he wrote. Companies that fail to raise either disappear or get acquired before reaching scale. Others move south for American capital, taking the jobs and intellectual property with them, he wrote.
Funded companies become Canadian employers and taxpayers, and their founders recycle wealth and experience into the next generation, he wrote. The Senate banking committee identified Canadian pension funds as an underused source of capital. Those are the same funds that lose when portfolio companies leave.
Bast cites Graphite's own results as evidence. Since the firm formed in 2021, its portfolio has grown to more than 140 Canadian companies. Over five years those companies created more than 1,350 new jobs and drew $800 million in follow-on capital, with more than $10 billion in new enterprise value, according to Graphite's data. Its newest fund is a $120 million, Canadian-focused seed fund anchored by $25 million each from the Province of Ontario and OMERS, plus another $25 million from Canadian founders.
Two Graphite portfolio outcomes illustrate the pitch. Nicoya Lifesciences, a Canadian scientific instruments maker, acquired Applied Photophysics, a British company, last year. The Canadian business became the acquirer; the British one became Nicoya's European hub. StackAdapt was started in Toronto a decade ago by three Russian immigrants with $750,000 of seed capital. The founders never raised significant outside money again for years, and the company is now valued at more than $3.5 billion, he wrote.
Carol Leaman, who built Axonify into a global enterprise software business before selling, now invests her own money alongside Graphite in the next generation of Canadian founders.
Canada is finally choosing to be a market maker rather than a market taker, Bast wrote. The urgency comes from the "investment behemoth to the south" reaching for Canadian companies and the intellectual property they hold. The tariffs apply the same pressure by other means. His goal is not to stop Canadian companies from competing globally. It is to help them remain distinctly Canadian while they scale.
"The capital exists, and the founders are building. The real danger isn't writing the cheques, but not writing the cheques and expecting to win," Bast wrote.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.